Endothelial Deletion of SHP2 Suppresses Tumor Angiogenesis and Promotes Vascular Normalization

Investigators showed that SHP2 was activated in tumor endothelia. Shp2 deletion and pharmacological inhibition reduced tumor growth and microvascular density in multiple mouse tumor models.